Fentanyl Transdermal Matrix Patch ZR-02-01

DRUG2 trials

Sponsors

ZARS Pharma Inc.

Conditions

CancerPain

Phase 3

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain

TerminatedNCT00126789

ZARS Pharma Inc.Cancer, Pain

Start: 2005-08-31End: 2007-07-31Updated: 2012-06-05

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant Pain

TerminatedNCT00126763

ZARS Pharma Inc.Pain

Start: 2005-07-31End: 2006-12-31Updated: 2012-06-05